SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study

SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study

Prostate-specific antigen (PSA) testing as the sole indication for prostate biopsy lacks specificity, resulting in overdiagnosis of indolent prostate cancer (PCa) and missing clinically significant PCa (csPCa). SelectMDx is a biomarker-based risk score to assess urinary HOXC6 and DLX1 mRNA expressio...

Full description

Bibliographic Details
Main Authors: Martina Maggi, Francesco Del Giudice, Ugo G. Falagario, Andrea Cocci, Giorgio Ivan Russo, Marina Di Mauro, Giuseppe Salvatore Sepe, Fabio Galasso, Rosario Leonardi, Gabriele Iacona, Peter R. Carroll, Matthew R. Cooperberg, Angelo Porreca, Matteo Ferro, Giuseppe Lucarelli, Daniela Terracciano, Luigi Cormio, Giuseppe Carrieri, Ettore De Berardinis, Alessandro Sciarra, Gian Maria Busetto
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cancers
Subjects:
prostate neoplasm
urinary biomarker
mpMRI
prostate biopsy
early detection
PSA
Online Access:https://www.mdpi.com/2072-6694/13/9/2047

Internet

https://www.mdpi.com/2072-6694/13/9/2047

Similar Items